United Drug has reported strong growth in all four of its divisions in the six months to the end of March.
In a trading statement, United said operating profits and earnings were expected to show double digit percentage growth over the same period last year.
In its pharmaceutical wholesale business, the company said it had managed a change to a new agreement on drug prices, which came into effect on March 1, 'very well'.
United's other divisions are supply chain services, medical and scientific and contract sales outsourcing. It said it expected the first half strength to continue in the second half.
Shares in United Drug closed down seven cent at €3.88 in Dublin this evening.
